久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • RedHill sees positive results for anti-MAP Crohn's drug pharmatimes
    July 31, 2018
    RedHill Biopharma has announced positive results from the first Phase III study of its Crohn's disease drug RHB-104 - making it the first global, double-blind, placebo-controlled study to demonstrates the efficacy of anti-MAP therapy in this hard-to-treat

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service